Pharmaceuticals

Pro

Healthcare

23 December, 2025

How did Quadria Capital fare in exit from six-year-old India portfolio company?

Healthcare-focused private equity firm Quadria Capital, which made the final close of its third fund with $1.07 billion (around Rs ......

Healthcare

22 December, 2025

Eight Roads-backed PlasmaGen Bio snags funding, valuation nears $170 mn

PlasmaGen Biosciences, a biopharmaceutical company which counts investors such as Eight Roads Ventures in its captable, has raised capital from ......

Premium

Healthcare

25 November, 2025

API maker SCL Lifesciences eyes maiden PE cheque, hires banker

Hyderabad-based pharmaceutical manufacturer SCL Lifesciences Ltd (formerly Saurav Chemicals) is eyeing its maiden round of external funding, at least two people ......

Healthcare

07 January, 2025

ChrysCapital-backed Intas Pharma strikes another overseas acquisition

Gujarat-based drugmaker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment ......

Premium

Healthcare

06 November, 2024

TA Associates-backed OmniActive Health acquires botanical drugs maker

Integrated nutraceutical ingredient manufacturer OmniActive Health Technologies Ltd, which is backed by the US-based private equity firm TA Associates, said ......

Healthcare

06 November, 2024

PE-backed pharma companies Sai Life and Rubicon Research get nod for IPO

Two homegrown healthcare companies, backed by private equity firms General Atlantic and TPG, have received approval from capital markets regulator ......

Premium

Healthcare

17 October, 2024

Symbiotec eyes IPO to give exit to PE investors; can it command a high valuation?

Bulk drug maker Symbiotec Pharmalab is planning to explore the possibility of floating an initial public offering in the next ......

Premium

Healthcare

16 October, 2024

India SME Investments makes second bet from latest fund

India SME Investments, a private equity firm that is currently in the process of raising its second fund, has made ......

Premium

Healthcare

27 September, 2024

Exclusive: KKR changes tack to monetise JB Pharma bet as suitors balk at valuation ask

Private equity giant KKR is considering a new multi-billion dollar plan to monetise its four-year-old bet on JB Chemicals & ......

Premium

Healthcare

27 September, 2024

What are Carlyle-backed Sequent Scientific's plans after recent merger announcement?

Private equity firm Carlyle-controlled SeQuent Scientific Ltd. aims to establish a larger platform focussed on pure-play animal health portfolio following ......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News